Auxilium Announces Appointments to Enhance Leadership Team

MALVERN, Pa., Feb. 6, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL - News), a specialty biopharmaceutical company, today announced the appointment of two executive officers, effective immediately.  ...

A huge American opportunity waiting to happen

Cellsonic machines can heal wounds, handle any mutant strain of malaria, and smooth out cellulite – but not in the US – and trials will be very, very expensive.

Cynosure Receives FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation

WESTFORD, Mass., Jan. 30, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO - News) today announced that the U.S. Food and Drug Administration has cleared the Company's Cellulaze™ Workstation for commercial distribution, ...

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study

MALVERN, Pa., Jan. 26, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL - News), a specialty biopharmaceutical company, today announced that the first cohort of patients has been dosed in its ...

Syneron Announces New Ground Breaking evolastin™ Procedure

IRVINE, Calif., Feb. 2, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS - News), www.syneron.com , the global leader in medical aesthetic products and technology, announces the launch of evolastin™– the ...